Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that John Cox, president and chief executive officer, is […]
NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Skye Bioscience, Inc. (NASDAQ:SKYE) securities. If you suffered a loss on your Skye Bioscience, Inc. investment and would like to explore
Nasdaq Debut, Healthcare Deployments, Global Expansion, and Accelerating Innovation INDIANAPOLIS, INDIANA / ACCESS Newswire / January 7, 2026 / Arrive AI (NASDAQ:ARAI), the autonomous delivery network company powering secure, AI-driven delivery for healthcare and enterprise, today released its 2025 Year in Review, highlighting major public-market, product, partnership, and intellectual property milestones achieved throughout the year.
NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Firefly Aerospace Inc. (NASDAQ:FLY) securities. If you suffered a loss on your Firefly Aerospace Inc. investment and would like to explore
Sheridan, Jan. 07, 2026 (GLOBE NEWSWIRE) — According to the latest market report published by Wissen Research, the global Animal Parasiticides market was valued at 11.2 billion in 2024. Furthermore, the market is expected to grow at a CAGR of 6 % during the forecast period from 2025 to 2030. Animal Parasiticides Market Report Pricing
Animal parasiticides market to grow at a CAGR of 6% during the forecast period (2025 – 2030): Wissen Research The global animal parasiticides market was valued at USD 11.2 billion in 2024 and is projected to reach USD 15.8 billion by 2030, expected to grow at a CAGR of 6 % during the forecast period,
(NASDAQ:DCX), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (NASDAQ: DCX) (“DCX” or the “Company”), a digital asset treasury management company specializing in cryptocurrency custody and storage infrastructure, today announced the execution of a staking agreement with EdgeAI Foundation (the “Foundation”) to stake a portion of its EdgeAI token holdings.
Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (NASDAQ: DCX) (“DCX” or the “Company”), a digital asset treasury management company specializing in cryptocurrency custody and storage infrastructure, today announced the execution of
(OtherOTC:GLUC),(OTC US:GLUC), BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed that all members of the Board of Directors holding preferred shares elected to convert their shares, along with all other preferred shareholders, at a shareholder-friendly 85% premium
Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy GlobeNewswire January 07, 2026 BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed that all members